Combined General Meeting of June 3, 2026
DBV Technologies, a late-stage biopharmaceutical company specializing in treatments for food allergies via its VIASKIN® patch technology, announced its Combined General Meeting to be held on June 3, 2026. The company has published meeting details, draft resolutions, and voting instructions, making all preparatory materials accessible to shareholder…